Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA), arginine, and 8-iso-prostaglandin F2alpha (8-iso-PGF2alpha) level in patients with inflammatory bowel diseases.
about
Endothelial dysfunction in inflammatory bowel diseases: Pathogenesis, assessment and implicationsAsymmetric dimethylarginine as a mediator of vascular dysfunction in cirrhosisSerum Concentrations of Symmetric Dimethylarginine and Creatinine in Dogs with Naturally Occurring Chronic Kidney DiseaseRelationship between lean body mass and serum renal biomarkers in healthy dogsCirculating microparticles from Crohn's disease patients cause endothelial and vascular dysfunctions.The issue of plasma asymmetric dimethylarginine reference range - A systematic review and meta-analysisInflammatory bowel disease: epidemiology, pathology and risk factors for hypercoagulability.Toxic Dimethylarginines: Asymmetric Dimethylarginine (ADMA) and Symmetric Dimethylarginine (SDMA).Propionyl-L-Carnitine is Efficacious in Ulcerative Colitis Through its Action on the Immune Function and Microvasculature.Levels and activities of von Willebrand factor and metalloproteinase with thrombospondin type-1 motif, number 13 in inflammatory bowel diseases.A randomized controlled trial on the effect of vitamin D3 on inflammation and cathelicidin gene expression in ulcerative colitis patientsReduced plasma fibrin clot permeability and susceptibility to lysis in patients with inflammatory bowel disease: a novel prothrombotic mechanism.Effect of alpha-lipoic acid on asymmetric dimethylarginine and disability in multiple sclerosis patients: A randomized clinical trial.
P2860
Q26774558-5BEA2950-DE12-471B-8E12-2EDB1C09ABC7Q26795604-028F45B3-9A2D-444D-AFAD-E64B0DD57EADQ28601037-C4BD2569-E1AA-4850-A6A3-A6576A854B7AQ28601638-75F7A120-1A60-4C91-9FC5-3B507C5A73F8Q31137300-73049A65-5AF1-4895-BECD-18B5789912C7Q33664224-B40F8266-FA5C-4D37-A88D-56EBB676B313Q37454573-4456324B-2D70-4BB5-9BD2-2C25949A66BDQ37727924-166C89F1-CEC9-4A94-9E23-A4849C3E5052Q38588839-D661EE32-ED96-4B4E-A7AA-34601487B2AAQ40110462-CEDB7457-3C23-45EA-B585-EF43577D1270Q40637403-E92D6988-EDF4-4843-B205-B19D8F126DF1Q42245018-7F01DCA1-1A03-4D8D-A719-A076BE0AC920Q50144469-0ED70418-C19C-466A-9505-6D2616C5C8BB
P2860
Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA), arginine, and 8-iso-prostaglandin F2alpha (8-iso-PGF2alpha) level in patients with inflammatory bowel diseases.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Asymmetric dimethylarginine (A ...... h inflammatory bowel diseases.
@en
Asymmetric dimethylarginine (A ...... h inflammatory bowel diseases.
@nl
type
label
Asymmetric dimethylarginine (A ...... h inflammatory bowel diseases.
@en
Asymmetric dimethylarginine (A ...... h inflammatory bowel diseases.
@nl
prefLabel
Asymmetric dimethylarginine (A ...... h inflammatory bowel diseases.
@en
Asymmetric dimethylarginine (A ...... h inflammatory bowel diseases.
@nl
P2093
P2860
P356
P1476
Asymmetric dimethylarginine (A ...... h inflammatory bowel diseases.
@en
P2093
Danuta Owczarek
Dorota Cibor
Tomasz Mach
P2860
P356
10.1002/IBD.20994
P577
2010-01-01T00:00:00Z